LENNOX GASTAUT SYNDROME
Clinical trials for LENNOX GASTAUT SYNDROME explained in plain language.
Never miss a new study
Get alerted when new LENNOX GASTAUT SYNDROME trials appear
Sign up with your email to follow new studies for LENNOX GASTAUT SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for hard-to-treat seizures: experimental drug enters final testing phase
Disease control Recruiting nowThis study tests whether an experimental drug called clemizole HCl can help reduce seizures in people with Lennox-Gastaut syndrome, a severe form of epilepsy that often starts in childhood. About 260 children and adults aged 2 to 55 will receive either the drug or a placebo along…
Matched conditions: LENNOX GASTAUT SYNDROME
Phase: PHASE3 • Sponsor: Epygenix • Aim: Disease control
Last updated May 07, 2026 18:38 UTC
-
CBD study tracks seizure control in Tough-to-Treat epilepsies
Symptom relief Recruiting nowThis study follows about 100 people with Lennox-Gastaut, Dravet, or tuberous sclerosis complex who are prescribed Epidyolex (a CBD liquid) alongside their usual seizure medicines. Researchers will track how long people stay on the treatment and how many seizure-free days they hav…
Matched conditions: LENNOX GASTAUT SYNDROME
Sponsor: Jazz Pharmaceuticals • Aim: Symptom relief
Last updated May 26, 2026 04:37 UTC